Bliss GVS Pharma has disclosed details of its Promoters and Promoter Group, including their PAN information for the financial year ended March 31, 2025. This update confirms the identities and shareholding credentials of key stakeholders, ensuring transparency and aiding shareholder confidence in the company’s ownership structure.